VanEck Biotech ETF · NASDAQ
↓ $1.83 (0.74%)
Last close · Oct 23, 4:00 PM ET
Sign up free to see this.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about BBH?
Zacks Investment Research
Biotech ETF (BBH) Hits New 52-Week HighVanEck Biotech ETF (BBH) has reached a 52-week high, rising 41.1% from its low, driven by positive Phase 3 results for Amgen and AstraZeneca's Tezspire treatment for eosinophilic esophagitis. The fund shows a positive weighted alpha of 44.96, suggesting potential for continued gains in the near term.
Headlines link to the publisher. Not investment advice.
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
No sentiment yet
Sign in to post on $BBH
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
